Viridian Therapeutics logo

Viridian Therapeutics Share Price Today

(NASDAQ: VRDN)

Viridian Therapeutics share price is $15.28 & ₹1,328.89 as on 6 Mar 2025, 2.30 'hrs' IST

$15.28

▲

0.05

(0.36%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Viridian Therapeutics share price in Dollar and Rupees. Guide to invest in Viridian Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Viridian Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Viridian Therapeutics share price movements

  • Today's Low: $15.11
    Today's High: $15.58

    Day's Volatility :3.05%

  • 52 Weeks Low: $11.40
    52 Weeks High: $27.20

    52 Weeks Volatility :58.09%

Viridian Therapeutics (VRDN) Returns

PeriodViridian Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-22.44%
2.1%
0.0%
6 Months
13.03%
-4.1%
0.0%
1 Year
-18.01%
2.2%
0.0%
3 Years
43.23%
11.8%
-11.6%

Viridian Therapeutics (VRDN) Key Statistics

in dollars & INR

Previous Close
$15.225
Open
$15.28
Today's High
$15.58
Today's Low
$15.105
Market Capitalization
$1.2B
Today's Volume
$454.1K
52 Week High
$27.2
52 Week Low
$11.4
Revenue TTM
$302.0K
EBITDA
$-298.5M
Earnings Per Share (EPS)
$-4.32
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-46.97%

How to invest in Viridian Therapeutics Stock (VRDN) from India?

It is very easy for Indian residents to invest directly in Viridian Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Viridian Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Viridian Therapeutics or VRDN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Viridian Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Viridian Therapeutics shares which would translate to 0.057 fractional shares of Viridian Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Viridian Therapeutics, in just a few clicks!

Returns in Viridian Therapeutics (VRDN) for Indian investors in Rupees

The Viridian Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Viridian Therapeutics investment value today

Current value as on today

₹87,246

Returns

₹12,754

(-12.75%)

Returns from Viridian Therapeutics Stock

₹17,717 (-17.72%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Viridian Therapeutics (VRDN)

0%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Viridian Therapeutics Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Viridian Therapeutics

  • FMR Inc

    14.67%

  • BlackRock Inc

    7.11%

  • Vanguard Group Inc

    5.67%

  • Deep Track Capital, LP

    5.58%

  • VR Adviser, LLC

    4.79%

  • State Street Corp

    4.35%

Analyst Recommendation on Viridian Therapeutics

Buy

    95%Buy

    4%Hold

    0%Sell

Based on 21 Wall street analysts offering stock ratings for Viridian Therapeutics(by analysts ranked 0 to 5 stars)

Based on 21 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
20
20
20
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Viridian Therapeutics Stock (VRDN)

What analysts predicted

Upside of 161.78%

Target:

$40.00

Current:

$15.28

Insights on Viridian Therapeutics Stock (Ticker Symbol: VRDN)

  • Price Movement

    In the last 1 month, VRDN stock has moved down by -20.9%

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 72.0K → 86.0K (in $), with an average increase of 16.3% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -48.54M → -76.68M (in $), with an average decrease of 25.9% per quarter

  • VRDN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 78.2%

  • Price to Sales

    ForVRDN every $1 of sales, investors are willing to pay $3806.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

VRDN Viridian Therapeutics Financials in INR & Dollars

FY18Y/Y Change
Revenue
$8.4M
↑ 109.49%
Net Income
$-32.7M
↑ 23.35%
Net Profit Margin
-389.97%
↑ 272.33%
FY19Y/Y Change
Revenue
$4.5M
↓ 46.8%
Net Income
$-42.4M
↑ 29.71%
Net Profit Margin
-950.91%
↓ 560.94%
FY20Y/Y Change
Revenue
$1.1M
↓ 76.46%
Net Income
$-111.0M
↑ 161.63%
Net Profit Margin
-10.6K%
↓ 9618.99%
FY21Y/Y Change
Revenue
$3.0M
↑ 182.19%
Net Income
$-79.4M
↓ 28.44%
Net Profit Margin
-2.7K%
↑ 7889.64%
FY22Y/Y Change
Revenue
$1.8M
↓ 40.2%
Net Income
$-125.4M
↑ 57.96%
Net Profit Margin
-7.1K%
↓ 4398.97%
FY23Y/Y Change
Revenue
$314.0K
↓ 82.28%
Net Income
$-237.7M
↑ 89.51%
Net Profit Margin
-75.7K%
↓ 68632.23%
Q2 FY23Q/Q Change
Revenue
$72.0K
↓ 26.53%
Net Income
$-55.1M
↓ 19.08%
Net Profit Margin
-76.5K%
↓ 7041.7%
Q3 FY23Q/Q Change
Revenue
$72.0K
↑ 0.0%
Net Income
$-47.7M
↓ 13.44%
Net Profit Margin
-66.2K%
↑ 10281.95%
Q4 FY23Q/Q Change
Revenue
$72.0K
↑ 0.0%
Net Income
$-66.9M
↑ 40.29%
Net Profit Margin
-92.9K%
↓ 26666.67%
Q1 FY24Q/Q Change
Revenue
$72.0K
↑ 0.0%
Net Income
$-48.5M
↓ 27.4%
Net Profit Margin
-67.4K%
↑ 25441.67%
Q2 FY24Q/Q Change
Revenue
$72.0K
↑ 0.0%
Net Income
$-65.0M
↑ 33.89%
Net Profit Margin
-90.3K%
↓ 22848.61%
Q3 FY24Q/Q Change
Revenue
$86.0K
↑ 19.44%
Net Income
$-76.7M
↑ 18.0%
Net Profit Margin
-89.2K%
↑ 1094.79%
FY18Y/Y Change
Profit
$8.4M
↑ 109.49%
FY19Y/Y Change
Profit
$-28.3M
↓ 437.86%
FY20Y/Y Change
Profit
$-27.3M
↓ 3.81%
FY21Y/Y Change
Profit
$2.3M
↓ 108.6%
FY22Y/Y Change
Profit
$1.0M
↓ 56.59%
FY23Y/Y Change
Profit
$-1.0M
↓ 199.12%
Q2 FY23Q/Q Change
Profit
$-360.0K
↑ 236.45%
Q3 FY23Q/Q Change
Profit
$-263.0K
↓ 26.94%
Q4 FY23Q/Q Change
Profit
$-278.0K
↑ 5.7%
Q1 FY24Q/Q Change
Profit
$-273.0K
↓ 1.8%
Q2 FY24Q/Q Change
Profit
$-5.7M
↑ 1994.87%
Q3 FY24Q/Q Change
Profit
$86.0K
↓ 101.5%
FY18Y/Y Change
Operating Cash Flow
$-26.8M
↓ 4.7%
Investing Cash Flow
$-29.9M
↓ 2992.36%
Financing Cash Flow
$41.9M
↓ 20.11%
FY19Y/Y Change
Operating Cash Flow
$-36.1M
↑ 34.32%
Investing Cash Flow
$28.2M
↓ 194.38%
Financing Cash Flow
$70.0K
↓ 99.83%
FY20Y/Y Change
Operating Cash Flow
$-29.8M
↓ 17.41%
Investing Cash Flow
$-50.5M
↓ 278.85%
Financing Cash Flow
$101.3M
↑ 144630.0%
FY21Y/Y Change
Operating Cash Flow
$-54.6M
↑ 83.29%
Investing Cash Flow
$-74.3M
↑ 47.17%
Financing Cash Flow
$125.3M
↑ 23.65%
FY22Y/Y Change
Operating Cash Flow
$-93.8M
↑ 71.92%
Investing Cash Flow
$-115.1M
↑ 54.96%
Financing Cash Flow
$322.2M
↑ 157.23%
Q2 FY23Q/Q Change
Operating Cash Flow
$-45.2M
↓ 27.04%
Investing Cash Flow
$40.7M
↓ 406.23%
Financing Cash Flow
$3.1M
↓ 62.6%

Viridian Therapeutics Technicals Summary

Sell

Neutral

Buy

Viridian Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Viridian Therapeutics (VRDN) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Viridian Therapeutics Inc logo
Viridian Therapeutics Inc
-21.11%
13.03%
-18.01%
43.23%
43.23%
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
Beone Medicines Ltd
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Viridian Therapeutics Inc logo
Viridian Therapeutics Inc
NA
NA
NA
-4.07
-0.47
-0.32
NA
6.55
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
Beone Medicines Ltd
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Viridian Therapeutics Inc logo
Viridian Therapeutics Inc
Buy
$1.2B
43.23%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
Beone Medicines Ltd
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
Buy
$31.5B
120.93%
NA
-12.37%

About Viridian Therapeutics

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.
Organization
Viridian Therapeutics
Employees
0
CEO
Mr. Stephen F. Mahoney J.D., MBA
Industry
Healthcare

Management People of Viridian Therapeutics

NameTitle
Mr. Stephen F. Mahoney J.D., MBA
CEO, President & Director
Mr. Seth Harmon
Chief Financial Officer
Mr. Thomas W. Beetham J.D., MBA
Chief Operating Officer
Dr. Eric N. Olson Ph.D.
Co-Founder & Chairman of Scientific Advisory Board
Dr. Michael R. Bristow M.D., Ph.D.
Co-Founder & Member of the Scientific Advisory Board
Dr. Marvin H. Caruthers Ph.D.
Co-Founder & Scientific Advisory Board Member
Mr. Vahe Bedian Ph.D.
Co-Founder & Scientific Advisor
Ms. Jennifer Tousignant J.D.
Chief Legal Officer
Ms. Melissa Manno
Chief Human Resources Officer
Mr. Anthony Casciano
Chief Commercial Officer

Important FAQs about investing in VRDN Stock from India :

What is Viridian Therapeutics share price today?

Viridian Therapeutics share price today stands at $15.28, Open: $15.28 ; Previous Close: $15.23 ; High: $15.58 ; Low: $15.11 ; 52 Week High: $27.20 ; 52 Week Low: $11.40.

The stock opens at $15.28, after a previous close of $15.23. The stock reached a daily high of $15.58 and a low of $15.11, with a 52-week high of $27.20 and a 52-week low of $11.40.

Can Indians buy Viridian Therapeutics shares?

Yes, Indians can invest in the Viridian Therapeutics (VRDN) from India.

With INDmoney, you can buy Viridian Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Viridian Therapeutics at zero transaction cost.

How can I buy Viridian Therapeutics shares from India?

It is very easy to buy Viridian Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Viridian Therapeutics (VRDN) be purchased?

Yes, you can buy fractional shares of Viridian Therapeutics with INDmoney app.

What are the documents required to start investing in Viridian Therapeutics stocks?

To start investing in Viridian Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Viridian Therapeutics Stock (VRDN)?

Today’s highest price of Viridian Therapeutics (VRDN) is $15.58.

Today’s lowest price of Viridian Therapeutics (VRDN) is $15.11.

What is today's market capitalisation of Viridian Therapeutics?

Today's market capitalisation of Viridian Therapeutics VRDN is 1.2B

What is the 52 Week High and Low Range of Viridian Therapeutics Stock (VRDN)?

  • 52 Week High

    $27.20

  • 52 Week Low

    $11.40

What are the historical returns of Viridian Therapeutics (VRDN)?

  • 1 Month Returns

    -21.11%

  • 3 Months Returns

    13.03%

  • 1 Year Returns

    -18.01%

  • 5 Years Returns

    43.23%

Who is the Chief Executive Officer (CEO) of Viridian Therapeutics ?

Mr. Stephen F. Mahoney J.D., MBA is the current Chief Executive Officer (CEO) of Viridian Therapeutics.